Overview
- German outlets republished a first-person interview in which a woman remained pregnant in 2021 despite taking the morning-after pill and undergoing a medication abortion with Mifegyne.
- At a follow-up visit, her doctor observed signs of an ongoing pregnancy, after which she chose to continue it and is now a mother, later reporting she has three children.
- The reports note that Mifegyne fails in an estimated 2–4% of cases, underscoring a documented but uncommon medical outcome.
- She says she supports access to abortion and does not regret seeking one, stressing that her positive experience with motherhood should not be generalized.
- In background, abortion in Germany remains criminalized under §218 StGB except under defined exemptions, and a 2023 UN report and rights groups have criticized requirements such as mandatory counseling, waiting periods, and typical self-payment of costs.